BAD investment firm launches flagship ETF | National company



OVERLAND PARK, Kan. – (BUSINESS WIRE) – December 22, 2021–

The investment company BAD is pleased to announce the launch of the BAD ETF (NYSE: BAD). The Large Cap Index Fund is designed to provide investors with equal weight exposure to BAD market segments – betting (casinos, gaming and online gaming operations); alcohol / cannabis (manufacture and distribution of alcoholic beverages and / or cultivation and sale of cannabis); and drugs (pharmaceutical and biotechnology product development and manufacturing) – providing investment results that closely track the performance, before fees and expenses, of the EQM BAD index (BADIDX).

While the idea of ​​creating vice equity-focused funds is not new, The BAD Investment Company saw a new opportunity to form a fund around ADB market segments specifically due to the nature of how companies in these market segments are often treated – We believe that the vice industry has defensive characteristics (people often continue to do BAD things regardless of economic conditions), but are often “avoided” and segments under -market investments that have historically provided diversification benefits, economic resilience and competitive risk-adjusted returns.

The BAD ETF also represents an attractive alternative for a new wave of retail investors who may be frustrated with certain aspects of the ESG movement.

“With the proliferation of whitewashed ESG products and increasingly socially and legally accepted market sub-segments like sports betting and cannabis, we saw an opportunity to fill what we saw as a gap in the market. We came to this conclusion primarily by listening to and observing this crowd of newly energized retailers over the past year, ”said Tommy Mancuso, President and Co-Founder of The BAD Investment Company. “We believe they want investment products that are built on transparency and quality that they can also understand and identify with as consumers, whether in the area of ​​health, wellness or healthcare. entertainment.”

The ADB Investment Company is embracing these changing trends not only to create a diversified product across multiple areas of vice, but also to provide investors with exposure to long-term growth opportunities. Mancuso added, “Many new or retail investors may have a misconception and ‘over the moon’ mindset when it comes to investing and as exciting as it sounds we think they should focus on long-term investing and sustainable areas of the market that have historically proven to be profitable and have withstood multiple business cycles.

“Our mission is to position ourselves in a unique way compared to most fund management companies. We are of the opinion that we do not think or dress like the typical ‘costume’, but that we are quite capable of harnessing the expertise and knowledge of Wall Street to deliver investment products strategically. designed. “

The BAD ETF now trades on the NYSE (NYSE: BAD).

For more information on the BAD ETF, please visit

About the investment company BAD

The investment firm BAD is a registered investment adviser and sponsor of ETFs. We focus on identifying market themes and sectors that may be of interest to investors as consumers and provide them with long-term sustainable investment opportunities. To learn more about the company, please visit


Before investing, carefully consider the investment objective, risks, costs and expenses of the fund. This and other information is contained in the prospectus which can be obtained by visiting Please read the prospectus carefully before investing.

The Fund is a recently incorporated investment company with no previous operating history. As a result, potential investors do not have a track record or history on which to base their investment decision.

Alcohol, betting, pharmaceutical and cannabis companies are subject to many risks. These industries face intense competition, especially from participants engaged in illegal activities or unregulated businesses. Betting, pharmaceutical and cannabis companies are particularly affected by the increase in regulatory constraints and the costs associated with complying with these constraints.

Alcohol companies in particular are subject to demographic and product trends, changing consumer preferences, nutritional and health concerns, competitive pricing, marketing campaigns and environmental factors.

Pharmaceutical companies can be significantly affected by government approval of products and services, government regulations and reimbursement rates, price pressure (including price discounts), limited product lines, price pressure ( including price discounts), limited product lines, patent expirations and intense competition. The costs associated with the development of new drugs can be significant and the results are unpredictable.

Cannabis-related companies are subject to various laws and regulations which may differ at national / local and federal level. These laws and regulations can (i) significantly affect the ability of a cannabis-related business to obtain financing, (ii) impact the market for sales and services of the marijuana industry, and ( iii) impose limits on the use, production, transportation and storage of marijuana. In addition, cannabis-related businesses are subject to the risks associated with the entire agricultural industry, including changes or trends that affect commodity prices, labor costs, conditions. meteorological and environmental protection, health and safety laws and regulations.

Distributor: Foreside Fund Services, LLC.

See the source version on

CONTACT: Ally Boyle

For: The investment company BAD

Phone. : 267-614-4076



SOURCE: The investment company BAD

Copyright Business Wire 2021.

PUB: 12/22/2021 09:02 / DISC: 12/22/2021 09:02



Comments are closed.